Key Mover for Sep 30: $UTHR (▲12.55%)
Strongest stock in the snapshot, up 12.55% on the day and 13.97% over 3 days despite weak market breadth.

Anomalous Activity for Sep 30: $UTHR
$UTHR stands out as a fresh statistical outlier: Capital Flow +5.7σ and Relative Return +7.7σ after mostly quiet prior sessions. That is one of the strongest same-day flow/price convergences in the dataset.

Anomaly Analysis for Sep 30:
Cross-sectional dispersion is elevated. $UTHR shows Capital Flow +5.7σ with Relative Return +7.7σ, while $JBL and $MSOS pair heavy Capital Flow with sharp Relative Return weakness. Bond ETFs like $VTEB remain persistent laggards.

#UTHR United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia

https://www.stocktitan.net/news/UTHR/united-therapeutics-corporation-prevails-in-patent-litigation-x8g58kv2gmy9.html?utm_source=stocktitan-bluesky&utm_medium=social

📈 TOP 10 DAILY GAINERS · US-LISTED LARGE CAPS

🟢 United Therapeutics Co #UTHR +13%
🟢 FormFactor, Inc. FORM +10%
🟢 JFrog Ltd. FROG +7%
🟢 ImmunityBio, Inc. IBRX +7%
🟢 Gen Digital Inc. GEN +6%
🟢 Synopsys, Inc. SNPS +5%
🟢 Pershing Square Inc. PS +4%
🟢 Hewlett Packard Enterp

https://financier.news/

📈 $UTHR +9.66% surges despite recent Goldman Sachs Sell rating
🚨 Z-score 6.12σ | RVOL 1.6x
#UTHR #Healthcare

Full breakdown: https://premarketprice.com/analysis/UTHR?utm_source=bluesky&utm_medium=social&utm_campaign=movers